ADHD management during the COVID-19 pandemic:   guidance from the European ADHD Guidelines Group

Samuele Cortese; Philip Asherson; Edmund Sonuga-Barke; Tobias Banaschewski; Daniel Brandeis; Jan Buitelaar; David Coghill; David Daley; Marina Danckaerts; Ralf W. Dittmann; Manfred Doepfner; Maite Ferrin; Chris Hollis; Martin Holtmann; Eric Konofal; Michel Lecendreux; Paramala Santosh; Aribert Rothenberger; César Soutullo; Hans Christoph Steinhausen; Eric Taylor; Saskia Van der Oord; Ian Wong; Alessandro Zuddas; Emily Simonoff

doi:10.1016/S2352-4642(20)30110-3

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group

Samuele Cortese, Philip Asherson, Edmund Sonuga-Barke, Tobias Banaschewski, Daniel Brandeis, Jan Buitelaar, David Coghill, David Daley, Marina Danckaerts, Ralf W. Dittmann, Manfred Doepfner, Maite Ferrin, Chris Hollis, Martin Holtmann, Eric Konofal, Michel Lecendreux, Paramala Santosh, Aribert Rothenberger, César Soutullo, Hans Christoph SteinhausenEric Taylor, Saskia Van der Oord, Ian Wong, Alessandro Zuddas, Emily Simonoff,

Research output: Contribution to journal › Letter, comment/opinion or interview › peer-review

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is creating unprecedented challenges at every level of society. Individuals with neurodevelopmental disorders, such as attention-deficit hyperactivity disorder (ADHD), are particularly vulnerable to the distress caused by the pandemic and physical distancing measures, and they might display increased behavioural problems. The crisis also poses several important questions for clinicians on how best to deliver care within the new restrictions. Therefore, the European ADHD Guidelines Group (EAGG) has developed guidance on the assessment and management of ADHD during the COVID-19 virus pandemic (see full guidance in the appendix).

Original language	English
Pages (from-to)	412-414
Number of pages	3
Journal	The Lancet Child and Adolescent Health
Volume	4
Issue number	6
Early online date	17 Apr 2020
DOIs	https://doi.org/10.1016/S2352-4642(20)30110-3
Publication status	Published - 1 Jun 2020

Access to Document

10.1016/S2352-4642(20)30110-3

Cite this

Cortese, S., Asherson, P., Sonuga-Barke, E., Banaschewski, T., Brandeis, D., Buitelaar, J., Coghill, D., Daley, D., Danckaerts, M., Dittmann, R. W., Doepfner, M., Ferrin, M., Hollis, C., Holtmann, M., Konofal, E., Lecendreux, M., Santosh, P., Rothenberger, A., Soutullo, C. (2020). ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group. The Lancet Child and Adolescent Health, 4(6), 412-414. https://doi.org/10.1016/S2352-4642(20)30110-3

@article{904def15758141669e4062e84af80a36,

title = "ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group",

abstract = "The coronavirus disease 2019 (COVID-19) pandemic is creating unprecedented challenges at every level of society. Individuals with neurodevelopmental disorders, such as attention-deficit hyperactivity disorder (ADHD), are particularly vulnerable to the distress caused by the pandemic and physical distancing measures, and they might display increased behavioural problems. The crisis also poses several important questions for clinicians on how best to deliver care within the new restrictions. Therefore, the European ADHD Guidelines Group (EAGG) has developed guidance on the assessment and management of ADHD during the COVID-19 virus pandemic (see full guidance in the appendix).",

author = "Samuele Cortese and Philip Asherson and Edmund Sonuga-Barke and Tobias Banaschewski and Daniel Brandeis and Jan Buitelaar and David Coghill and David Daley and Marina Danckaerts and Dittmann, {Ralf W.} and Manfred Doepfner and Maite Ferrin and Chris Hollis and Martin Holtmann and Eric Konofal and Michel Lecendreux and Paramala Santosh and Aribert Rothenberger and C{\'e}sar Soutullo and Steinhausen, {Hans Christoph} and Eric Taylor and {Van der Oord}, Saskia and Ian Wong and Alessandro Zuddas and Emily Simonoff",

year = "2020",

month = jun,

day = "1",

doi = "10.1016/S2352-4642(20)30110-3",

language = "English",

volume = "4",

pages = "412--414",

number = "6",

}

Cortese, S, Asherson, P, Sonuga-Barke, E, Banaschewski, T, Brandeis, D, Buitelaar, J, Coghill, D, Daley, D, Danckaerts, M, Dittmann, RW, Doepfner, M, Ferrin, M, Hollis, C, Holtmann, M, Konofal, E, Lecendreux, M, Santosh, P, Rothenberger, A, Soutullo, C, Steinhausen, HC, Taylor, E, Van der Oord, S, Wong, I, Zuddas, A, Simonoff, E 2020, 'ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group', The Lancet Child and Adolescent Health, vol. 4, no. 6, pp. 412-414. https://doi.org/10.1016/S2352-4642(20)30110-3

TY - JOUR

T1 - ADHD management during the COVID-19 pandemic

T2 - guidance from the European ADHD Guidelines Group

AU - Cortese, Samuele

AU - Asherson, Philip

AU - Sonuga-Barke, Edmund

AU - Banaschewski, Tobias

AU - Brandeis, Daniel

AU - Buitelaar, Jan

AU - Coghill, David

AU - Daley, David

AU - Danckaerts, Marina

AU - Dittmann, Ralf W.

AU - Doepfner, Manfred

AU - Ferrin, Maite

AU - Hollis, Chris

AU - Holtmann, Martin

AU - Konofal, Eric

AU - Lecendreux, Michel

AU - Santosh, Paramala

AU - Rothenberger, Aribert

AU - Soutullo, César

AU - Steinhausen, Hans Christoph

AU - Taylor, Eric

AU - Van der Oord, Saskia

AU - Wong, Ian

AU - Zuddas, Alessandro

AU - Simonoff, Emily

PY - 2020/6/1

Y1 - 2020/6/1

N2 - The coronavirus disease 2019 (COVID-19) pandemic is creating unprecedented challenges at every level of society. Individuals with neurodevelopmental disorders, such as attention-deficit hyperactivity disorder (ADHD), are particularly vulnerable to the distress caused by the pandemic and physical distancing measures, and they might display increased behavioural problems. The crisis also poses several important questions for clinicians on how best to deliver care within the new restrictions. Therefore, the European ADHD Guidelines Group (EAGG) has developed guidance on the assessment and management of ADHD during the COVID-19 virus pandemic (see full guidance in the appendix).

AB - The coronavirus disease 2019 (COVID-19) pandemic is creating unprecedented challenges at every level of society. Individuals with neurodevelopmental disorders, such as attention-deficit hyperactivity disorder (ADHD), are particularly vulnerable to the distress caused by the pandemic and physical distancing measures, and they might display increased behavioural problems. The crisis also poses several important questions for clinicians on how best to deliver care within the new restrictions. Therefore, the European ADHD Guidelines Group (EAGG) has developed guidance on the assessment and management of ADHD during the COVID-19 virus pandemic (see full guidance in the appendix).

UR - http://www.scopus.com/inward/record.url?scp=85083486928&partnerID=8YFLogxK

UR - https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30110-3/fulltext

U2 - 10.1016/S2352-4642(20)30110-3

DO - 10.1016/S2352-4642(20)30110-3

M3 - Letter, comment/opinion or interview

C2 - 32311314

AN - SCOPUS:85083486928

SN - 2352-4642

VL - 4

SP - 412

EP - 414

JO - The Lancet Child and Adolescent Health

JF - The Lancet Child and Adolescent Health

IS - 6

ER -

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group

Abstract

Access to Document

Other files and links

Fingerprint

Cite this